Medtronic (MDT) reported first-quarter fiscal 2027 revenue of $9.756 billion, up 13.7% reported and organic, for the quarter ended July 31, 2026. GAAP net income attributable to Medtronic was $1.470 billion, while diluted GAAP earnings per share were $1.14.
The company raised fiscal 2027 organic revenue growth guidance to 7.25% to 7.75% and lifted diluted non-GAAP EPS guidance to $5.94 to $6.00.
- Cardiovascular revenue was $3.927 billion, up 19.5% reported and 18.9% organic.
- Neuroscience revenue totaled $2.678 billion, up 10.3% reported and 9.3% organic.
- Medical Surgical revenue was $2.279 billion, up 10.0% reported and 10.2% organic.
- Diabetes revenue reached $843 million, up 16.9% reported and 14.9% organic.
- The company estimated that an extra fiscal week benefited first-quarter organic growth by about $570 million.
$MDT Insider Trading Activity
$MDT insiders have traded $MDT stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MDT stock by insiders over the last 6 months:
- HARRY SKIP KIIL (EVP & President Cardiovascular) has made 0 purchases and 2 sales selling 4,189 shares for an estimated $336,965.
- MATTHEW R. WALTER (SVP, Chief HR Officer) sold 3,102 shares for an estimated $257,931
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MDT Hedge Fund Activity
We have seen 998 institutional investors add shares of $MDT stock to their portfolio, and 1,337 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 28,665,280 shares (-68.4%) from their portfolio in Q2 2026, for an estimated $2,242,484,854
- JPMORGAN CHASE & CO added 27,784,471 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,173,579,166
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 9,106,059 shares (-93.6%) from their portfolio in Q2 2026, for an estimated $712,366,995
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 8,905,319 shares (+inf%) to their portfolio in Q2 2026, for an estimated $696,663,105
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 8,233,285 shares (+176.7%) to their portfolio in Q2 2026, for an estimated $644,089,885
- CAPITAL WORLD INVESTORS removed 8,134,242 shares (-49.3%) from their portfolio in Q2 2026, for an estimated $636,341,751
- SG AMERICAS SECURITIES, LLC added 6,500,749 shares (+inf%) to their portfolio in Q2 2026, for an estimated $508,553,594
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MDT Congressional Stock Trading
Members of Congress have traded $MDT stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MDT stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK sold up to $15,000 on 07/30.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/15.
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
